On Tuesday, the medical authority said they were aware of the decision of their US colleagues to put a halt on the use of that particular vaccine due to the rare occasion of blood clots shaping in patients' bodies.
"It is not clear there is a link between the vaccine and the incidents and its safety committee is continuing a review announced last week", the story reads.
Earlier, the American regulators recommend putting a temporary halt to the use of the Johnson & Johnson vaccine in the vaccination campaign. Six cases of blood clots occurred among U.S. patients who were vaccinated with this particular drug. All ladies are aged from 18 to 48. Six to thirteen days after the vaccination, blood clots appeared in their bodies. One patient deceased, and one more was hospitalized in grave condition.